All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This gene encodes a PTEN-related tyrosine phosphatase which may play a role in the signal transduction pathways of the endocrine or spermatogenic function of the testis. Alternative splicing results in multiple transcript variants.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-L167 | Human anti-TPTE T cell receptor (TCRCD8-TPT#3), pCDTCR1 | Human | TCRCD8-TPT#3 | Human | YPSDFAVEI | HLA-B3501 | Lentiviral | |
TCR-L168 | Human anti-TPTE T cell receptor (TCRCD8-TPT#35), pCDTCR1 | Human | TCRCD8-TPT#35 | Human | PRWTHLLRL | HLA-B*0702 | Lentiviral | |
TCR-L169 | Human anti-TPTE T cell receptor (TCRCD4-TPT#4), pCDTCR1 | Human | TCRCD4-TPT#4 | Human | NWNLPPRRILFIKHFIIYS | HLA-DRB4*1101 | Lentiviral | |
TCR-L170 | Human anti-TPTE T cell receptor (TCRCD4-TPT#5), pCDTCR1 | Human | TCRCD4-TPT#5 | Human | KHFIIYSIPRYVRDLKIQI | HLA-DRB1*1401 | Lentiviral | |
TCR-L171 | Human anti-TPTE T cell receptor (TCRCD4-TPT#6), pCDTCR1 | Human | TCRCD4-TPT#6 | Human | SPISESVLARLSKFEVEDA | HLA-DRB1*1401 | Lentiviral | |
TCR-L172 | Human anti-TPTE T cell receptor (TCRCD4-TPT#8), pCDTCR1 | Human | TCRCD4-TPT#8 | Human | IKLLRNIPRWTHLLR | HLA-DRB3*0201/2 | Lentiviral | |
TCR-L173 | Human anti-TPTE T cell receptor (TCRCD4-TPT#11), pCDTCR1 | Human | TCRCD4-TPT#11 | Human | ILADLIFTDSKLYIPLEYR | HLA-DRB1*0701 | Lentiviral | |
TCR-L174 | Human anti-TPTE T cell receptor (TCRCD4-TPT#13), pCDTCR1 | Human | TCRCD4-TPT#13 | Human | WLHTSFIENNRLYLPKNEL | HLA-DRB1*1401 | Lentiviral | |
TCR-L175 | Human anti-TPTE T cell receptor (TCRCD4-TPT#17), pCDTCR1 | Human | TCRCD4-TPT#17 | Human | IFFDIKLLRNIPRWTHLLR | HLA-DRB5*0202 | Lentiviral | |
TCR-L176 | Human anti-TPTE T cell receptor (TCRCD4-TPT#27), pCDTCR1 | Human | TCRCD4-TPT#27 | Human | IKLLRNIPRWTHLLR | HLA-DRB3*0301 | Lentiviral | |
TCR-L177 | Human anti-TPTE T cell receptor (TCRCD4-TPT#33), pCDTCR1 | Human | TCRCD4-TPT#33 | Human | KLIRRRVSENKRRYT | HLA-DRB5*0202 | Lentiviral | |
TCR-L178 | Human anti-TPTE T cell receptor (TCRCD4-TPT#38), pCDTCR1 | Human | TCRCD4-TPT#38 | Human | NHYRVYNLCSERAYD | HLA-DRB1*1601 | Lentiviral | |
TCR-L179 | Human anti-TPTE T cell receptor (TCRCD4-TPT#42), pCDTCR1 | Human | TCRCD4-TPT#42 | Human | RFLDKKHRNHYRVYN | HLA-DRB1*1301 | Lentiviral | |
TCR-L180 | Human anti-TPTE T cell receptor (TCRCD4-TPT#45), pCDTCR1 | Human | TCRCD4-TPT#45 | Human | ILFIKHFIIYSIPRY | HLA-DRB1*1501 | Lentiviral | |
TCR-L181 | Human anti-TPTE T cell receptor (TCRCD4-TPT#48), pCDTCR1 | Human | TCRCD4-TPT#48 | Human | DVVYIFFDIKLLRNI | HLA-DRB1*1501 | Lentiviral | |
TCR-L182 | Human anti-TPTE T cell receptor (TCRCD4-TPT#49), pCDTCR1 | Human | TCRCD4-TPT#49 | Human | YVAYFAQVKHLYNWNLPPR | HLA-DRB1*1501 | Lentiviral | |
TCR-L183 | Human anti-TPTE T cell receptor (TCRCD4-TPT#51), pCDTCR1 | Human | TCRCD4-TPT#51 | Human | KLIRRRVSENKRRYT | HLA-DRB1*1301 | Lentiviral | |
TCR-L184 | Human anti-TPTE T cell receptor (TCRCD4-TPT#52), pCDTCR1 | Human | TCRCD4-TPT#52 | Human | DSKLYIPLEYRSISLAIAL | HLA-DRB1*1501 | Lentiviral | |
TCR-L185 | Human anti-TPTE T cell receptor (TCRCD4-TPT#54), pCDTCR1 | Human | TCRCD4-TPT#54 | Human | SPISESVLARLSKFE | HLA-DQB1*0602/03 | Lentiviral | |
TCR-L186 | Human anti-TPTE T cell receptor (TCRCD4-TPT#55), pCDTCR1 | Human | TCRCD4-TPT#55 | Human | IFFDIKLLRNIPRWTHLLR | HLA-DRB1*1301 | Lentiviral |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION